Buprenorphine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Buprenorphine and local guidelines before prescribing.

Partial mu-opioid agonist

Mechanism

Partial mu-opioid agonist with high receptor affinity and long duration.

Uses

Opioid dependence maintenance and chronic pain (transdermal).

Dosing

Side effects

Nausea, constipation, sedation, respiratory depression (ceiling effect), hepatitis with misuse.

Interactions

Other CNS depressants and benzodiazepines increase respiratory depression; precipitates withdrawal if started too early in full agonist users.

Contraindications and cautions

Acute respiratory depression; caution with benzodiazepines, liver disease

Monitoring

Sedation, respiratory rate, LFT

Pregnancy and breastfeeding

Specialist advice

Renal and hepatic impairment

Safe in renal impairment

Overdose and reversal

Naloxone may need high doses

Special advice

Start only when in mild withdrawal; slow-release patches change dose only after several days; naloxone supply for community settings.

More from the textbook: uses, cautions and other points
Where it is discussed in the book